Five things for pharma marketers to know: Thursday, December 29, 2022
FDA accepts Kala Pharmaceutical’s investigational new drug application for KPI-012; Supreme Court keeps Title 42 in effect.
Stay updated with breaking news from Kala Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA accepts Kala Pharmaceutical’s investigational new drug application for KPI-012; Supreme Court keeps Title 42 in effect.
Analysts expect Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) to post $3.06 million in sales for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Kala Pharmaceuticals’ earnings. The highest sales estimate is $4.20 million and the lowest is $1.76 million. Kala Pharmaceuticals posted sales of $3.05 million during the […]
Wall Street analysts expect Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) to report earnings of ($0.38) per share for the current fiscal quarter, Zacks Investment Research reports. Six analysts have issued estimates for Kala Pharmaceuticals’ earnings, with the highest EPS estimate coming in at ($0.30) and the lowest estimate coming in at ($0.43). Kala Pharmaceuticals […]
Wall Street brokerages predict that Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) will announce sales of $3.09 million for the current quarter, according to Zacks Investment Research. Six analysts have issued estimates for Kala Pharmaceuticals’ earnings, with estimates ranging from $2.04 million to $5.00 million. Kala Pharmaceuticals reported sales of $3.27 million during the same […]
Analysts expect Kala Pharmaceuticals, Inc. (NASDAQ:KALA – Get Rating) to announce sales of $3.38 million for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for Kala Pharmaceuticals’ earnings. The highest sales estimate is $3.50 million and the lowest is $3.24 million. Kala Pharmaceuticals posted sales of $2.24 million during the […]